When we treated two HCC cells and two colon cancer cells with siRNA for SMYD2 (siSMYD2), significant downregulation of both CCND1 and cMYC was observed in concordance with the decrease of nuclear β-catenin in all of these four cell lines (Figure 3A). This evidence concerns the gene SMYD2 and colonic neoplasm.